Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell, Peripheral × Immunologic Factors × Clear all

NCT05182957 2026-05-01

Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma

Phase 2 Recruiting

Lymphoma, T-Cell, Peripheral